Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?

Literals

vivo:identifier
- 2009-367
dcterms:creator
- Agúndez J.
dcterms:contributor
- Agúndez, J.A.G., García-Martín, E., Martínez, C.
ou:bibtex
- @article{García-Martín2009,title = {Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?},journal = {Expert Opinion on Drug Metabolism and Toxicology},year = {2009},volume = {5},number = {6},pages = {607-620},author = {Ag{\'u}ndez, J.A.G. and Garc{\'i}a-Mart{\'i}n, E. and Mart{\'i}nez, C.}}
dcterms:publisher
- Expert Opinion on Drug Metabolism and Toxicology
dcterms:title
- Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?
fabio:hasPublicationYear
- 2009
bibo:page_range
- 607-620
bibo:doi
- 10.1517/17425250902970998
ou:eid
- 2-s2.0-67649416267
bibo:issn
- 1742-5255
ou:tipoPublicacion
- Review
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=67649416267&origin=inward
ou:urlOrcid
- http://www.scopus.com/inward/record.url?eid=2-s2.0-67649416267&partnerID=MN8TOARS
ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=67649416267&origin=inward
bibo:volume
- 5